Education
About Us
Working with TipRanks
Follow Us
Albert D. Dyrness Insider Profile
4 Followers
Albert D. Dyrness, Director at Oncobiologics Inc, holds ― shares in Oncobiologics Inc (Ticker: ONSIU), holds ― shares in Outlook Therapeutics (Ticker: OTLK), holds 4.54K shares in Sonnet BioTherapeutics Holdings (Ticker: SONN). Most recently, Albert D. Dyrness ― shares of Oncobiologics Inc on ― for an estimated value of ―.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-71.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Albert D. Dyrness holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 12, 2020 - Jun 12, 2021
Return:-57.20%
The most profitable trade made by Albert D. Dyrness
Albert D. Dyrness's Trading History
Oncobiologics Inc
―
―
―
―
Outlook Therapeutics
―
Director
―
―
Sonnet BioTherapeutics Holdings
Jul 15, 2025
Director
Uninformative Buy
―
$14.47K
List of latest transactions for each holding click on a transaction to see Albert D. Dyrness's performance on stock
You May Also Like
Albert D. Dyrness insider profile FAQ
What is the percentage of profitable transactions made by Albert D. Dyrness?
The percentage of profitable transactions made by Albert D. Dyrness is 0%.
What is the average return per transaction made by Albert D. Dyrness?
The average return per transaction made by Albert D. Dyrness is -71.60%.
What stocks does Albert D. Dyrness hold?
Albert D. Dyrness holds: ONSIU, OTLK, SONN stocks.
What was Albert D. Dyrness’s latest transaction?
Albert D. Dyrness latest transaction was an Uninformative Buy of ―.
What was Albert D. Dyrness's most profitable transaction?
Albert D. Dyrness’s most profitable transaction was an Informative Buy of SONN stock on June 12, 2020. The return on the trade was -57.20%.
What is Albert D. Dyrness's role in Oncobiologics Inc?
Albert D. Dyrness's role in Oncobiologics Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.